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The trends and types of carbapenemase-producing Gram-negative bacilli were an-
alyzed from clinical specimens collected between 2005 and 2012 at a Korean 
teaching hospital. The proportions of carbapenem-resistant Acinetobacter spp. in-
creased markedly to 66%. Metallo-β-lactamase producers significantly decreased 
and the majority shifted from the blaVIM-2 type to the blaIMP-1 type.
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Carbapenems such as imipenem and meropenem are first-line drugs in the treat-
ment of serious infections caused by multidrug-resistant Pseudomonas aeruginosa, 
Acinetobacter spp., and Enterobacteriaceae. However, in recent years, imipenem 
resistance in P. aeruginosa and Acinetobacter spp. has been increasing steadily 
around the world, and in Korea, these resistance rates reached 22% and 64%, re-
spectively, in 2011.1 Among several mechanisms of carbapenem resistance, acquired 
metallo-β-lactamases (MBLs) have a more serious impact as the enzymes confer a 
high level of resistance and the genes can be transferred horizontally.2,3 Among ac-
quired MBLs, VIM-type and IMP-type enzymes are the most common types of 
MBLs with worldwide distribution,4 and the VIM-2 type has been highly preva-
lent in Korea.5,6 In our previous study in 2003‒2004, imipenem-nonsusceptible P. 
aeruginosa isolates carrying the blaVIM-2 allele were highly prevalent, and the inci-
dence of Acinetobacter spp. carrying the blaVIM-2 allele had increased compared to 
those carrying the blaIMP-1 allele.5 The aim of the present study was to determine the 
trends of carbapenem-resistant and MBL-producing Gram-negative bacilli over the 
past 8 years in a Korean teaching hospital with more than 2000 beds. This is a 
unique report on the long term trend of carbapenem-resistant and MBL-producing 
Gram-negative bacilli isolated in a single hospital.
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modified Hodge test (MHT) and the imipenem and ethyl-
enediaminetetraacetic acid sodium mercaptoacetic acid dou-
ble disk potentiation (IEDDP) test were conducted to screen 
for MBL producers in imipenem- or meropenem-nonsus-
ceptible isolates.8 Polymerase chain reaction (PCR) was per-
formed to detect and sequence blaVIM-2-like, blaIMP-1-like and 
blaSIM-1-like genes.9,10 In carbapenem-nonsusceptible strains 
showing MHT-positive yet the aforementioned PCR nega-
tive results, blaNDM and blaKPC genes were also screened by 
PCR.11,12 The nucleotide sequences of PCR-generated ampli-
cons were analyzed for the representative strains. XbaI- or 
SmaI-digested genomic DNAs from 75 P. aeruginosa, 8 P. 
In total, non-duplicated clinical isolates of 12650 P. aeru-
ginosa, 1096 other Pseudomonas spp., and 7650 Acineto-
bacter spp. in addition to 14026 Klebsiella pneumoniae, 
6110 Enterobacter cloacae, and 3162 Serratia marcescens 
isolates among Enterobacteriaceae were recovered from 
patients at the hospital from 2005 to 2012 (Table 1). The iso-
lates were identified by conventional methods using ATB 32 
GN or VITEK-2 systems (bioMerieux, Marcy-l’E´toile, 
France). Antimicrobial susceptibilities were determined us-
ing the disk-diffusion method or the VITEK-2 system 
(bioMerieux). The Clinical and Laboratory Standards Insti-
tute 2010 breakpoints were used after January 2011.7 The 
Table 1. Annual Imipenem Resistance Rates and MBL-Producing Clinical Isolates over 8 Years
Species Yr
No. of isolates 
(% imipenem 
resistance)
No. (%) of carbapenem-nonsusceptible isolates with positive results
Tested Modified Hodge test
Double disk  
potentiation test  
blaVIM-2
-like gene
blaIMP-1
-like gene
blaSIM-1
-like gene
P. aeruginosa
2005   1409 (21) 474   102 (22)   39 (8)   37 (95)     2 (5)   0
2006   1635 (20) 454     92 (20)   39 (9)   26 (67)   13 (33)   0
2007   1675 (24) 513   36 (7)   20 (4)   16 (80)     4 (20)   0
2008   1777 (22) 465     66 (14)   41 (9)   14 (34)   27 (66)   0
2009   1721 (29) 631     63 (10)   50 (8)   28 (56)   22 (44)   0
2010   1383 (25) 604     86 (14)   29 (5)*   10 (34)   20 (69)   0
2011   1510 (19) 361   23 (6)   10 (3)     5 (50)     5 (50)   0
2012   1540 (23) 575     77 (13)   15 (3)   10 (67)     5 (33)   0
Subtotal 12650 (23) 4077   545 (13) 243 (6) 146 (61)   98 (40)   0
Other 
  Pseudomonas 
  spp.
2005     137 (34) 6       3 (50)     3 (50)     3 (100)     0   0
2006     157 (35) 34     29 (85)   25 (74)   24 (96)     1 (4)   0
2007     142 (32) 27     20 (74)   20 (74)   17 (85)     3 (15)   0
2008     126 (34) 26     19 (73)   18 (69)   18 (100)     0   0
2009     102 (31) 26     19 (73)   14 (54)   13 (93)     1 (7)   0
2010     137 (27) 35     27 (77)   27 (77)   26 (96)     1 (4)   0
2011     166 (27) 56     28 (50)   26 (46)   25 (96)     1 (4)   0
2012     129 (33) 37     25 (68)   24 (65)   23 (96)     1 (4)   0
Subtotal   1096 (32) 247   170 (69) 157 (64) 149 (95)     8 (5)   0
Acinetobacter 
  spp.
2005     793 (29) 358   332 (93)   72 (20)†   21 (29)   38 (53) 14 (19)
2006     847 (15) 302   245 (81)   42 (14)*   12 (29)   26 (62)   6 (14)
2007     721 (16) 159   115 (72)   33 (21)*   17 (52)   15 (45)   2 (6) 
2008   1158 (39) 447   399 (89)   41 (9)   13 (32)   28 (68)   0
2009   1141 (58) 668   660 (99)   32 (5)     8 (25)   19 (59)   5 (16) 
2010   1100 (64) 828   799 (97)   20 (2)     7 (35)   12 (60)   1 (5) 
2011     885 (61) 510   485 (95)     9 (2)‡     5 (56)     2 (22)   0
2012   1005 (66) 726   723 (99)   13 (2)*     2 (15)   11 (85)   1 (8)
Subtotal   7650 (46) 3998 3758 (94) 262 (7)   85 (37) 151 (58) 29 (11) 
K. pneumoniae 2005‒2012 14026 (<1) 205     25 (12)     2 (1)     2 (100)     0   0
E. cloacae 2005‒2012   6110 (<1) 36     20 (56)     3 (8)     2 (67)     1 (33)   0
S. marcescens 2005‒2012   3162 (<1) 13       6 (46)     1 (8)     1 (100)     0   0
MBL, metallo-β-lactamase.
*Both blaVIM-2-like and blaIMP-1-like genes were detected in two isolates in 2006 and one isolate per year in 2007, 2010, and 2012. 
†Both a blaVIM-2-like gene and a blaSIM-1-like gene were detected in one isolate.
‡An NDM-1 gene was detected in two isolates.
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Likewise, Cavalcanti, et al.19 reported that a higher preva-
lence of MBL-producing P. aeruginosa was observed in 
2002‒2003 in Brazil, while the level decreased significant-
ly in 2008‒2009, suggesting that the resistance to carbapen-
ems by these recent P. aeruginosa isolates was not due to 
the spread of MBL-positive clones. In this study, P. aerugi-
nosa isolates carrying a blaVIM-2-like gene were highly prev-
alent, comprising 90% to 100% of the P. aeruginosa strains 
in 2003 to 2004,5 although they were reduced to 34% while 
those with blaIMP-1-like genes increased to 69% in 2010.
Among MBL-producing Acinetobacter spp. isolates, the 
prevalence of blaIMP-1-like genes also increased to 85% in 
2012. The range of strains carrying blaSIM-1-like genes re-
mained low. Two isolates carrying blaNDM-1-like genes that 
were isolated in 2011 were identified as A. pitti and A. guil-
louiae. To our knowledge, this is the first report of a clinical 
isolate of A. guillouiae carrying the blaNDM-1-like gene. 
Most of the other Pseudomonas spp. isolates carrying MBL 
genes were identified as P. putida, and their MBL genes 
were blaVIM-2-like. 
Among the 254 carbapenem-nonsusceptible Enterobac-
teriaceae, only five isolates, two K. pneumoniae, two E. 
cloacae, and one S. marcescens, produced MBL, suggest-
ing that the major carbapenem resistance mechanism in En-
terobacteriaceae was not MBL. Our results support previ-
ous reports that suggested that carbapenem resistance in 
Enterobacteriaceae was comediated with AmpC beta-lacta-
mase and outer membrane protein loss in K. pneumoniae, 
E. cloacae, and S. marcescens.20-22
PFGE analysis revealed that the pulsotypes of IMP-6- and 
VIM-2-producing P. aeruginosa strains were clearly separat-
ed. The major pulsotypes in the IMP-6-producing P. aerugi-
nosa were A2 and A3, while those in the VIM-2-producing 
P. aeruginosa were A1 and C1 types (Table 2). Likewise, the 
pulsotypes of Acinetobacter spp. isolates obviously differed 
according to MBL type (Table 2). These findings suggest 
that the plasmids carrying the MBL gene are not promiscu-
ous, although they do have clone preference. Interestingly, 
Acinetobacter spp. isolates in the E1, H1, I4, J3, N1, and Q 
subgroups showed identical PFGE patterns, despite the dif-
ferences in species. This suggests that the identification of 
Acinetobacter species is important for evaluating clonal 
outbreaks in hospital settings, as the misinterpretation of a 
clonal outbreak occurred among the different species.
Other mechanisms may block the cross-over of resistance 
plasmids between clones. Further study is warranted to eluci-
date this supposition. The hybridization of S1-digested DNA 
putida, and 109 Acinetobacter spp., all of which were ran-
domly selected MBL-producing spp. isolated in 2005‒ 
2006, were separated by pulsed field gel electrophoresis 
(PFGE) using a CHEF-DR II system (Bio-Rad, Hercules, 
CA, USA) and BioNumerics software v. 5.10 (Applied 
Maths, Sint-Martens-Latem, Belgium). PFGE banding pat-
tern clustering with an 80% similarity threshold was deter-
mined using the Dice coefficients and the unweighted pair 
group method using arithmetic averages using Molecular 
Analyst Fingerprinting Software (Bio-Rad). Related clones 
with one or two independent genetic events were designat-
ed as subtype numbers in Table 2. The S1-digested DNA of 
randomly selected P. aeruginosa, Pseudomonas putida, and 
Acinetobacter spp. strains carrying the blaVIM-2 allele were 
blotted onto nylon membranes (Bio-Rad) and hybridized 
with blaVIM-2 gene probes to observe the differences in the 
plasmids carrying the gene.
While annual imipenem resistance rates in P. aeruginosa 
increased from 14% in 2003 to 29% in 2009, they decreased 
from 58% in 2003 to 33% in 2012 in other Pseudomonas 
spp.; in Acinetobacter spp., resistance rates increased steeply 
from 13% in 2003 to 66% in 2012.5 However, the imipenem 
resistance rates in K. pneumoniae, E. cloacae, and S. marces-
cens isolates remained at less than 1%. The positive rates of 
MHT were highly variable depending on the species, being 
only 13% in P. aeruginosa isolates, yet reaching 69% in oth-
er Pseudomonas spp. and 94% in Acinetobacter spp. These 
findings suggest that the majority of other Pseudomonas and 
Acinetobacter spp. isolates clearly produced the carbapenem-
hydrolyzing enzymes to gain their resistance to carbapenem, 
while P. aeruginosa isolates obtained other resistance mecha-
nisms such as AmpC or extended spectrum β-lactamase and 
porin loss, as previously reported.13,14
Among the carbapenem-nonsusceptible isolates, MBL 
producers included only 6% (243 of 4077) of P. aeruginosa 
spp. and only 7% (262 of 3998) of Acinetobacter spp. Inter-
estingly, 157 of 247 (64%) of the other Pseudomonas spp. 
produced MBL, and almost all of them (152 of 157) were P. 
putida, which was a much higher incidence than those of the 
other species. These findings suggest that P. putida can be a 
reservoir for MBL, as previously described.15 Acinetobacter 
spp. with different carbapenem-resistance mechanisms, such 
as OXA-type β-lactamases, have become prevalent.16
In P. aeruginosa, the incidence of MBL producers in-
creased until the mid-2000s in this study, as shown in Ja-
pan,17 while in more recent years, these isolates gradually 
decreased in this study, as described in a previous report.18 
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Table 2. Pulsotypes of 109 MBL-Producing Acinetobacter spp. and 75 P. aeruginosa Isolates
Species with 
MBL genes 
A. pitti A. bereziniae A. nosocomialis A. junii A. genomosp 14TU Acinetobacter spp.* P. aeruginosa
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
IMP
-6
VIM
-2
A
    1 2 41
    2 7
    3 1 5
    4-7 1e
B
    1 2
    2-3 1e
C
    1 2
D
    1 1
E
    1 1 4 1
    2 1
    3 4
    4 1
    5 2
    6 1 2
    7 1
F
    1 7
    2 1
    3-5 1e
G
    1 1
    2-4 2e
    5-6 1e
    7 1
H
    1 5 1
    2 1
    3 2
    4 1
I
    1 2
    2 1
    3 2
    4 1 1
    5 1
J
    1 3
    2 1
    3 1 1
K
    1 3
    2 1
    3-4 1e
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Table 2. Pulsotypes of 109 MBL-Producing Acinetobacter spp. and 75 P. aeruginosa Isolates (Continued)
Species with 
MBL genes 
A. pitti A. bereziniae A. nosocomialis A. junii A. genomosp 14TU Acinetobacter spp.* P. aeruginosa
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
VIM
-2
SIM
-1
IMP
-1
IMP
-6
VIM
-2
L
    1 2
    2 1
    3 1
    4 1
M
    1 3
    2-3 1e
N
    1 1 1
    2-3 1e
O
    1 2
    2 1
P
    1-2 1e
    3 1
Q 1 1
R 2
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